Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database to identify adult patients who underwent liver resection between 2022 and 2023. Primary outcomes included 30-day mortality, sepsis, septic shock, readmission, and reoperation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Participant who underwent liver resection | Adult patients who underwent liver resection between January 2022 and December 2023. Data obtained from the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| 30-day mortality | Number of deaths at 30 days | 30 days |
| Number of participants with Sepsis | Number of participants with sepsis at 30 days | 30 days |
| Number of participants with Septic Shock | Number of participants with septic shock at 30 days | 30 days |
| Number of readmissions | Number of participants who had a remission at 30 days | 30 days |
| Number of reoperations | Number of participants who had an reoperation at 30 days | 30 days |
Not provided
Not provided
Inclusion Criteria:
- Retrospective patients with condition only
Exclusion Criteria:
- none
Not provided
Not provided
Not provided
Participants wit hepatic neoplasms
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael Leitman, MD | Icahn School of Medicine at Mount Sinai | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | United States |
All of the individual participant data collected during the trial, after deidentification.
Immediately following publication. No end date.
Investigators whose proposed use of the data has been approved by an independent review committee ('learned intermediary') identified for this purpose.
For individual participant data meta-analysis. Data are available indefinitely at (Link included in the URL field below).
Not provided
| ID | Term |
|---|---|
| D008113 | Liver Neoplasms |
| ID | Term |
|---|---|
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D008107 |
| Liver Diseases |